Suppression of IL-1β, IFN-γ as well as IL-6 (Fig. 7d, b and c) by the Riboflavin and CIP or AZM treated macrophages at late stage of infection further confirms their anti-inflammatory nature. The gene discussed is IL1B; the disease is infection.